Timothy Leach

Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study

Asit Parikh, Timothy Leach, Tim Wyant et al. · Inflammatory Bowel Diseases · 2011 · 207 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

A resource of targeted mutant mouse lines for 5,061 genes

Marie‐Christine Birling, Atsushi Yoshiki, David J. Adams et al. · Nature Genetics · 2021 · 114 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double‐blind, placebo‐controlled, randomized, proof‐of‐concept study

Clarissa E. Vergunst, Daniëlle M. Gerlag, Lisa Von Moltke et al. · Arthritis & Rheumatism · 2009 · 81 citations

Medicine, Pharmacology, Pharmacotherapy +13

Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease

Asit Parikh, Irving H. Fox, Timothy Leach et al. · Inflammatory Bowel Diseases · 2013 · 79 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +13

Feasibility of the Zero-V: A zero-emissions hydrogen fuel-cell coastal research vessel

Robert T. Madsen, Leonard E. Klebanoff, Sean Caughlan et al. · International Journal of Hydrogen Energy · 2020 · 72 citations

Engineering, Chemical Engineering, Environmental Engineering +10